0.64 USD
↗ 0.03 (4.73%)AT CLOSE (11:59 AM EDT)
Estrella Immunopharma, Inc. Common Stock
ESLANASDAQ • USD
0.64
↗ 0.00 (0.17%)
POST MARKET (AS OF 04:04 PM EDT)
Post Market
AS OF 04:04 PM EDT
0.64
↗ 0.00 (0.17%)
Market: OPEN
ESLA is currently priced at $0.64. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (134.7%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.
Technical & fundamental data as of Sep 15, 2026.
Open?$0.65
High?$0.65
Low?$0.59
Prev. Close?$0.61
Volume?45.2K
Avg. Volume?32.6K
VWAP?$0.63
Rel. Volume?1.39x
Bid / Ask
Bid?$0.52 × 100
Ask?$12.00 × 300
Spread?$11.48
Midpoint?$6.26
Valuation & Ratios
Market Cap?26.5M
Shares Out?43.5M
Float?15.1M
Float %?35.2%
P/E Ratio?N/A
P/B Ratio?-3.57
EPS?-$0.23
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Employees
N/A
Market Cap
26.6M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2023-10-02
Address
5858 HORTON STREET, SUITE 370
EMERYVILLE, CA 94608
Phone: (510) 318-9098
EMERYVILLE, CA 94608
Phone: (510) 318-9098
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?48
Piotroski F-Score?0/9Weak
Altman Z-Score?-52.78Distress
Confidence?54%Low
Short InterestModerate
Short % of Float?0.77%Low
Short Interest?117.1K
Days to Cover?3.4
Free Float15.1M
Avg Daily Volume34.6K
Settlement Date2026-08-31
Financial Health
Current Ratio?0.20Weak
Quick Ratio?0.20Weak
Cash Ratio?0.02Low
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?-3.57CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?134.7%STRONG▾
Peers50
S&P97
ROA?-548.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-9383567
Enterprise Value?$26.4M
Fundamentals ratios updated end of day